William John Scheessele insider trades
Open-market stock purchases and sales by William John Scheessele, Chief Commercial Officer at Humacyte, Inc, from SEC Form 4 filings since Oct 13, 2021.
Track record: 0% of 3 scored buys are up 5% or more since purchase, averaging -47%.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- HUMA Humacyte, Inc: 3 buys, last Apr 14, 2025
Get free alerts when William John Scheessele files a new trade →